14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ARGS
Delisted

Argos Therapeutics Fund Forecast

$0.0536
+0 (+0%)
At Close: Apr 15, 2020
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Argos Therapeutics Fund and on which exchange is it traded?
The symbol for Argos Therapeutics is ARGS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Argos Therapeutics Fund?
Argos Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Argos Therapeutics Fund?
Argos Therapeutics Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Argos Therapeutics Fund.

What's the current price of Argos Therapeutics Fund?
As of the end of day on the 2020-04-15, the price of an Argos Therapeutics (ARGS) share was $0.0536.

What is the 52-week high and low for Argos Therapeutics Fund?
The 52-week high for Argos Therapeutics Fund is $0.0840 and the 52-week low is $0.0350.
Click to get the best stock tips daily for free!

About Argos Therapeutics

Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its development stage products include AGS-003, which is under Phase III clinical trials for the treatment of metastatic renal cell carcinoma and other cancers; and AGS-004, which ... ARGS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT